Johan A Verhelst

Summary

Affiliation: University of Antwerp
Country: Belgium

Publications

  1. ncbi Active acromegaly is associated with decreased hs-CRP and NT-proBNP serum levels: insights from the Belgian registry of acromegaly
    Johan Verhelst
    Department of Endocrinology, ZNA Middelheim, Lindendreef 1, B 2020 Antwerp, Belgium
    Eur J Endocrinol 168:177-84. 2013
  2. ncbi Prevalence and characteristics of the metabolic syndrome in 2479 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis
    Johan Verhelst
    Department of Endocrinology, ZNA Middelheim Antwerp, Lindendreef 1, Antwerp, Belgium
    Eur J Endocrinol 165:881-9. 2011
  3. ncbi Remission of acromegaly following long-term therapy with cabergoline: report of two cases
    Johan A Verhelst
    Department of Endocrinology, ZNA Middelheim, Lindendreef 1, Antwerp 2020, Belgium
    Pituitary 11:103-7. 2008
  4. ncbi Baseline characteristics and response to 2 years of growth hormone (GH) replacement of hypopituitary patients with GH deficiency due to adult-onset craniopharyngioma in comparison with patients with nonfunctioning pituitary adenoma: data from KIMS (Pfizer
    Johan Verhelst
    General Hospital Middleheim, Antwerp, Belgium
    J Clin Endocrinol Metab 90:4636-43. 2005
  5. ncbi Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database
    Roger Abs
    Department of Endocrinology, University Hospital Antwerp, Wilrijkstraat 10, B 2650 Edegem, Belgium
    Growth Horm IGF Res 15:349-59. 2005
  6. ncbi Cardiovascular risk factors in hypopituitary GH-deficient adults
    Johan Verhelst
    Department of Endocrinology, ZNA Middelheim, Antwerp, Belgium
    Eur J Endocrinol 161:S41-9. 2009
  7. ncbi Modification of hormonal secretion in clinically silent pituitary adenomas
    Tania Daems
    Department of Endocrinology, University Hospital Antwerp, Wilrijkstraat 10, Edegem 2650, Belgium
    Pituitary 12:80-6. 2009
  8. ncbi Long-term growth hormone replacement therapy in hypopituitary adults
    Johan Verhelst
    Departments of Endocrinology, Middelheim Hospital and University Hospital, Antwerp, Belgium
    Drugs 62:2399-412. 2002
  9. ncbi Hyperprolactinemia: pathophysiology and management
    Johan Verhelst
    Department of Endocrinology, Middelheim Hospital, Antwerp, Belgium
    Treat Endocrinol 2:23-32. 2003
  10. ncbi The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma
    Pat Kendall-Taylor
    University of Newcastle, UK
    Eur J Endocrinol 152:557-67. 2005

Detail Information

Publications11

  1. ncbi Active acromegaly is associated with decreased hs-CRP and NT-proBNP serum levels: insights from the Belgian registry of acromegaly
    Johan Verhelst
    Department of Endocrinology, ZNA Middelheim, Lindendreef 1, B 2020 Antwerp, Belgium
    Eur J Endocrinol 168:177-84. 2013
    ..We examined whether changes in high-sensitive C-reactive protein (hs-CRP) and N-terminal pro-brain natriuretic peptide (NT-proBNP) might contribute to this phenomenon...
  2. ncbi Prevalence and characteristics of the metabolic syndrome in 2479 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis
    Johan Verhelst
    Department of Endocrinology, ZNA Middelheim Antwerp, Lindendreef 1, Antwerp, Belgium
    Eur J Endocrinol 165:881-9. 2011
    ..MetS was defined according to the National Cholesterol Education Program's Adult Treatment Panel III (NCEP) and the International Diabetes Foundation (IDF)...
  3. ncbi Remission of acromegaly following long-term therapy with cabergoline: report of two cases
    Johan A Verhelst
    Department of Endocrinology, ZNA Middelheim, Lindendreef 1, Antwerp 2020, Belgium
    Pituitary 11:103-7. 2008
    ..These two cases demonstrate that acromegalic patients with a good response to cabergoline may occasionally remain in remission after stopping therapy. This phenomenon has previously only been described in patients with a prolactinoma...
  4. ncbi Baseline characteristics and response to 2 years of growth hormone (GH) replacement of hypopituitary patients with GH deficiency due to adult-onset craniopharyngioma in comparison with patients with nonfunctioning pituitary adenoma: data from KIMS (Pfizer
    Johan Verhelst
    General Hospital Middleheim, Antwerp, Belgium
    J Clin Endocrinol Metab 90:4636-43. 2005
    ..To analyze this difference, we used the KIMS database (Pfizer International Metabolic Database) comparing CP and NFPA patients in terms of baseline characteristics and responses to GH replacement...
  5. ncbi Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database
    Roger Abs
    Department of Endocrinology, University Hospital Antwerp, Wilrijkstraat 10, B 2650 Edegem, Belgium
    Growth Horm IGF Res 15:349-59. 2005
    ....
  6. ncbi Cardiovascular risk factors in hypopituitary GH-deficient adults
    Johan Verhelst
    Department of Endocrinology, ZNA Middelheim, Antwerp, Belgium
    Eur J Endocrinol 161:S41-9. 2009
    ..No subgroup yet has been identified as not responding well to GH...
  7. ncbi Modification of hormonal secretion in clinically silent pituitary adenomas
    Tania Daems
    Department of Endocrinology, University Hospital Antwerp, Wilrijkstraat 10, Edegem 2650, Belgium
    Pituitary 12:80-6. 2009
    ..Silent corticotroph adenomas are the classical example of this phenomenon...
  8. ncbi Long-term growth hormone replacement therapy in hypopituitary adults
    Johan Verhelst
    Departments of Endocrinology, Middelheim Hospital and University Hospital, Antwerp, Belgium
    Drugs 62:2399-412. 2002
    ....
  9. ncbi Hyperprolactinemia: pathophysiology and management
    Johan Verhelst
    Department of Endocrinology, Middelheim Hospital, Antwerp, Belgium
    Treat Endocrinol 2:23-32. 2003
    ..In the small group of patients who do not respond to this treatment, or who refuse long-term therapy, surgery is offered. Radiotherapy is given if both pharmacologic therapy and surgery fail...
  10. ncbi The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma
    Pat Kendall-Taylor
    University of Newcastle, UK
    Eur J Endocrinol 152:557-67. 2005
    ..Craniopharyngioma is a parasellar tumour that, although benign, tends to behave aggressively. It can occur at any age but most commonly presents in childhood or adolescence...
  11. ncbi Changes in height, weight, and body mass index in children with craniopharyngioma after three years of growth hormone therapy: analysis of KIGS (Pfizer International Growth Database)
    Mitchell Geffner
    The Saban Research Institute of Childrens Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, California 90027, USA
    J Clin Endocrinol Metab 89:5435-40. 2004
    ....